Matches in Wikidata for { <http://www.wikidata.org/entity/Q56003948> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- Q56003948 description "article scientifique publié en 1982" @default.
- Q56003948 description "article" @default.
- Q56003948 description "im März 1982 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56003948 description "wetenschappelijk artikel" @default.
- Q56003948 description "наукова стаття, опублікована в березні 1982" @default.
- Q56003948 description "ലേഖനം" @default.
- Q56003948 name "Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men**Supported in part by the National Cancer Institute of Canada; Hoechst AG, Frankf" @default.
- Q56003948 name "Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men**Supported in part by the National Cancer Institute of Canada; Hoechst AG, Frankf" @default.
- Q56003948 type Item @default.
- Q56003948 label "Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men**Supported in part by the National Cancer Institute of Canada; Hoechst AG, Frankf" @default.
- Q56003948 label "Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men**Supported in part by the National Cancer Institute of Canada; Hoechst AG, Frankf" @default.
- Q56003948 prefLabel "Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men**Supported in part by the National Cancer Institute of Canada; Hoechst AG, Frankf" @default.
- Q56003948 prefLabel "Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men**Supported in part by the National Cancer Institute of Canada; Hoechst AG, Frankf" @default.
- Q56003948 P1433 Q56003948-08DA256E-11D5-4D2F-8C4E-127B3F4859F2 @default.
- Q56003948 P1476 Q56003948-F4F4E498-9390-469D-AF48-06DADF68552D @default.
- Q56003948 P2093 Q56003948-0192C808-9B50-4AA1-90A0-914A11F95DB8 @default.
- Q56003948 P2093 Q56003948-5D1EFD12-6850-4C2E-A73F-8973B9B26E57 @default.
- Q56003948 P2093 Q56003948-66BC6EC5-1BB0-4C52-BF76-B24E8ADF8516 @default.
- Q56003948 P2093 Q56003948-66F1CFA6-81CC-4455-8997-917ADF47E196 @default.
- Q56003948 P2093 Q56003948-B2E9342F-C196-4161-BD30-E8951343B375 @default.
- Q56003948 P2093 Q56003948-BC9EA808-C82B-4B9B-AA4F-35F0A9960685 @default.
- Q56003948 P2093 Q56003948-EF8C47BE-8AE9-4EAC-A6BA-E4D5FB891DD3 @default.
- Q56003948 P2860 Q56003948-0A8AD9E4-0C15-43A8-AAF9-2807493E06C4 @default.
- Q56003948 P2860 Q56003948-2048DA39-2B63-489E-960D-9958728B2F7E @default.
- Q56003948 P2860 Q56003948-31AA227A-7E24-49F6-98B0-76618BDEA4DF @default.
- Q56003948 P2860 Q56003948-38748F29-94B4-48DD-B10F-994785BEC986 @default.
- Q56003948 P2860 Q56003948-3BF836C6-2CBA-4E80-8D3A-0036126CEA17 @default.
- Q56003948 P2860 Q56003948-3C03FB99-B7EE-4EFF-BF92-FA93E9481D11 @default.
- Q56003948 P2860 Q56003948-3F6A9C3A-1EA4-49EA-AAD1-DC89AE575F36 @default.
- Q56003948 P2860 Q56003948-5186D094-8426-4CB1-90FE-2DF0BCE585E4 @default.
- Q56003948 P2860 Q56003948-685240B2-CA12-4548-B20D-87DDE17DAF43 @default.
- Q56003948 P2860 Q56003948-77357192-AF68-44F8-BC39-E1E9226BAE91 @default.
- Q56003948 P2860 Q56003948-903EAA18-39B3-4B7F-91A4-C25E8E2F189F @default.
- Q56003948 P2860 Q56003948-A4AA2EA9-FFFC-4419-9558-0C14352F0B2C @default.
- Q56003948 P2860 Q56003948-AC82A047-2B9B-47E7-BAF5-EB8492B51E42 @default.
- Q56003948 P2860 Q56003948-D40A1F5F-DD1E-49CC-9961-880AAFD10FAA @default.
- Q56003948 P2860 Q56003948-DAFB801C-FD3B-4C5D-BD15-C527FF36303F @default.
- Q56003948 P304 Q56003948-AEEEAC5B-A40B-4434-8FF8-7C594CBC5D52 @default.
- Q56003948 P31 Q56003948-AC838E22-E850-495D-A031-C485B7DA266C @default.
- Q56003948 P356 Q56003948-E64723F7-5EA7-4260-931C-E1E03C471808 @default.
- Q56003948 P407 Q56003948-223D2A09-D295-4DAE-AA79-CADEC542FC10 @default.
- Q56003948 P433 Q56003948-6DBEE173-E4E0-4210-806D-D07E3B6CEE0C @default.
- Q56003948 P478 Q56003948-1760AFDF-606A-488F-9BD6-D4AF2B10E60D @default.
- Q56003948 P577 Q56003948-0B6AED7F-9AF1-441D-BB35-6C121FC2214B @default.
- Q56003948 P921 Q56003948-686F020F-990D-4DA3-BCAF-26E454CFC155 @default.
- Q56003948 P356 S0015-0282(16)46107-8 @default.
- Q56003948 P1433 Q15724525 @default.
- Q56003948 P1476 "Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men**Supported in part by the National Cancer Institute of Canada; Hoechst AG, Frankf" @default.
- Q56003948 P2093 "Alain Bélanger" @default.
- Q56003948 P2093 "André Lemay" @default.
- Q56003948 P2093 "Bruno Laroche" @default.
- Q56003948 P2093 "Fernand Labrie" @default.
- Q56003948 P2093 "Gilles Robert" @default.
- Q56003948 P2093 "Nacia Faure" @default.
- Q56003948 P2093 "Yves Gourdeau" @default.
- Q56003948 P2860 Q39650054 @default.
- Q56003948 P2860 Q40096697 @default.
- Q56003948 P2860 Q40223419 @default.
- Q56003948 P2860 Q41004852 @default.
- Q56003948 P2860 Q48498425 @default.
- Q56003948 P2860 Q56114098 @default.
- Q56003948 P2860 Q68676953 @default.
- Q56003948 P2860 Q69506048 @default.
- Q56003948 P2860 Q69914001 @default.
- Q56003948 P2860 Q71505621 @default.
- Q56003948 P2860 Q71517553 @default.
- Q56003948 P2860 Q71523725 @default.
- Q56003948 P2860 Q72431562 @default.
- Q56003948 P2860 Q72853890 @default.
- Q56003948 P2860 Q72883041 @default.
- Q56003948 P304 "416-424" @default.
- Q56003948 P31 Q13442814 @default.
- Q56003948 P356 "10.1016/S0015-0282(16)46107-8" @default.
- Q56003948 P407 Q1860 @default.
- Q56003948 P433 "3" @default.
- Q56003948 P478 "37" @default.
- Q56003948 P577 "1982-03-01T00:00:00Z" @default.
- Q56003948 P921 Q16 @default.